Novartis enters into US$390 million settlement
Swiss drug maker Novartis has agreed to pay US state and federal authorities US$390 million to resolve allegations that the company paid kickbacks to speciality pharmacies. In return for kickbacks the pharmacies would recommend Novartis drugs to patients.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.